Obiettivo
SAPHIR aims to develop vaccine strategies effective against endemic pathogens responsible for high economic losses in livestock in order to strengthen the profitability of food animal systems, improve animal welfare and reduce xenobiotic usage in farming with a One Health perspective.
SAPHIR will bring novel vaccine strategies to the market i) at short term, with several promising vaccines brought to demonstration (RTL6), ii) at long term, with cutting edge strategies brought at proof of concept (RTL3) and iii) in line with socio-economic requirements. SAPHIR has selected two representative pathogens of pigs (Porcine Reproductive and Respiratory Syndrome Virus and Mycoplasma hyopneumoniae), chickens (Eimeria and Clostridium perfringens) and cattle (Bovine Respiratory Syncytial Virus, Mycoplasma bovis) to develop generic vaccine approaches applicable to other pathogens.
SAPHIR will issue i) knowledge of immune mechanisms of protection, ii) affordable, safe and multivalent vaccines with DIVA properties, iii) efficient adjuvants targeting dendritic cells, optimal formulations, new mucosal and skin delivery systems, a new generation of DNA vectors and viral replicon platforms for fostering an earlier and longer duration of immunity including the perinatal period, and iv) basal biomarkers of individual immuno-competence for future breeding strategies. The SAPHIR dissemination and training programme includes creation of an integrated health management website, launch of a Global Alliance for Veterinary Vaccines and organization of workshops directed at food animal system stakeholders. This will ensure optimal research translation of SAPHIR outputs to market and field applications.
SAPHIR brings together interdisciplinary expertise from fourteen academic institutes including a Chinese partner, five SMEs and two pharmaceutical companies.
Campo scientifico
Not validated
Not validated
Programma(i)
Meccanismo di finanziamento
RIA - Research and Innovation actionCoordinatore
75007 Paris
Francia
Mostra sulla mappa
Partecipanti (21)
CF24 0DE Cardiff
Mostra sulla mappa
3003 Bern
Mostra sulla mappa
2905 AT Capelle Aan Den Ijssel
Mostra sulla mappa
28037 MADRID
Mostra sulla mappa
75013 PARIS
Mostra sulla mappa
26900 LODI
Mostra sulla mappa
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.
200241 SHANGHAI
Mostra sulla mappa
NW1 0NH LONDON
Mostra sulla mappa
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.
6708 PB Wageningen
Mostra sulla mappa
750 07 Uppsala
Mostra sulla mappa
02 787 Warszawa
Mostra sulla mappa
GU24 0NF Woking
Mostra sulla mappa
NW1 OTU London
Mostra sulla mappa
3012 Bern
Mostra sulla mappa
1015 LAUSANNE
Mostra sulla mappa
9000 Gent
Mostra sulla mappa
EH8 9YL Edinburgh
Mostra sulla mappa
0349 OSLO
Mostra sulla mappa
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.
06511 CARROS
Mostra sulla mappa
5 KILLESTER
Mostra sulla mappa
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.
L69 7ZX Liverpool
Mostra sulla mappa